ArticleCancers2024

Proteomic Profiling Identifies Predictive Signatures for Progression Risk in Patients with Advanced-Stage Follicular Lymphoma.

Jonas Klejs Hemmingsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.